Detail akcie Teleflex online

Business Summary: Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, and vascular access. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of the MANTA Vascular Closure device, Arrow OnControl powered bone biopsy system, GuideLiner, Turnpike and TrapLiner catheters.
Financial Summary: BRIEF: For the six months ended 30 June 2026, Teleflex Inc revenues increased 31% to $1.12B. Net income before extraordinary items decreased 69% to $36.9M. Revenues reflect EMEA segment increase of 69% to $292.2M, Americas segment increase of 15% to $681.5M, Asia segment increase of 62% to $144.9M. Net income was offset by Unallocated expenses segment loss increase from $99.7M to $231.2M, EMEA segment income decrease of 34% to $20.6M.